Florence Vonmoos PhD | PMI Science

About Florence

I am responsible for leading the establishment of toxicological assessment strategies for both cigarettes and RRPs. I also support the development of new products through the toxicological assessment of ingredients, prototypes, and product designs intended to be used for human exposure, from early internal panels through to commercial launches.

Latest Publications

Show all

Contact Florence

Title

Name
Email
Message

Please succeed the reCAPTCHA challenge below.

Sorry an error occurs

Sorry an error occurs. Would you please retry to submit your question

Thanks

Thank you for getting in touch. We will get back to you as soon as possible. Your message will be vetted by our communications team to ensure the content is relevant before it is released to our employee.

PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts to develop and assess products that have the potential to reduce individual risk and population harm associated with tobacco use. This site is for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not for advertising or marketing. It is not intended for use by consumers.

Our RRPs

Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. Our RRPs are smoke-free products that produce an aerosol that contains far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.